ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

GRFS Company Profile and Key Details

NASDAQ : GRFS

Grifols SA

$10.70

-0.04-0.37%

Open: 11:45 AM

64.77

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Grifols, S.A. (GRFS) stock declined over -0.37%, trading at $10.70 on NASDAQ, down from the previous close of $10.74. The stock opened at $10.73, fluctuating between $10.65 and $10.77 in the recent session.

Stock Snapshot

10.74

Prev. Close

9.05B

Market Cap

10.65

Day Low

20.98

P/E Ratio

0.51

EPS (TTM)

-0.05

Cash Flow per Share

10.73

Open

845.97M

Number of Shares

10.77

Day High

99.94%

Free Float in %

8.58

Book Value

373.51K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Aug 14, 2025	10.62	10.84	10.40	10.74	3.94M
Aug 13, 2025	10.76	10.78	10.54	10.64	1.16M
Aug 12, 2025	10.43	10.68	10.38	10.60	757.9K
Aug 11, 2025	10.57	10.63	10.35	10.60	797.15K
Aug 08, 2025	10.72	10.79	10.60	10.66	751.59K
Aug 07, 2025	10.60	10.82	10.51	10.65	1.04M
Aug 06, 2025	10.60	10.71	10.41	10.48	1.37M
Aug 05, 2025	10.80	10.83	10.57	10.63	1.47M
Aug 04, 2025	10.84	10.88	10.69	10.72	558.7K
Aug 01, 2025	10.60	10.86	10.60	10.78	1.33M
Jul 31, 2025	10.60	10.85	10.59	10.70	838.8K
Jul 30, 2025	10.77	11.14	10.73	10.85	1.19M
Jul 29, 2025	10.07	10.50	9.53	10.50	3.65M
Jul 28, 2025	10.11	10.16	9.99	10.09	531.2K
Jul 25, 2025	10.00	10.17	9.99	10.10	784.24K
Jul 24, 2025	9.99	10.09	9.93	9.94	732.06K
Jul 23, 2025	9.92	9.97	9.76	9.85	1.12M
Jul 22, 2025	9.94	10.00	9.66	9.66	1.35M
Jul 21, 2025	9.84	10.04	9.79	10.00	1.54M
Jul 18, 2025	10.03	10.15	9.84	9.94	796.12K

Contact Details

Barcelona, 08174

Spain

https://www.grifols.com 349 357 10221

About Company

Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solutions to treat patients with chronic, rare, prevalent, and life-threatening diseases. It offers immunoglobulins, alpha-1 antitrypsin, albumin, clotting factors, and hyperimmune globulins. The Hospital division offers non-biological pharmaceutical products and medical supplies clinical nutrition, intravenous therapy, and medical devices. The Diagnostic division researches, develops, produces, and commercializes diagnostic products that span the healthcare continuumfrom prevention, screening, diagnosis, and prognosis to disease and treatment monitoringto serve professionals. The Bio Supplies division provides biological materials for life-science research, clinical trials, and for manufacturing pharmaceutical and diagnostic products. Its products and services are used by healthcare providers to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases, and other medical conditions. The company serves public and private customers; and wholesalers, distributors, group purchasing organizations, blood banks, hospitals and care institutions, and national health systems. Grifols, S.A. has a technology collaboration agreement with Mondragon. The company was founded in 1940 and is headquartered in Barcelona, Spain.

Stock Peers

AMGN

0.96+0.33%

Amgen Inc.$290.29 BIIB

-0.26-0.19%

Biogen Inc.$134.94 GILD

-1.12-0.93%

Gilead Sciences, Inc.$119.02 HZNP

Horizon Therapeutics Public Limited Company$116.30 AZN

0.53+0.68%

AstraZeneca PLC$78.47 SNY

0.3+0.62%

Sanofi$49.04 SCLX

-3.63-17.29%

Scilex Holding Company$17.37 CTOR

-0.07-3.91%

Citius Oncology, Inc.$1.72 MIRA

-0.02-1.34%

MIRA Pharmaceuticals, Inc.$1.47 SCLXW

-0.1359-24.38%

Scilex Holding Company$0.42

Company Overview

Grifols, S.A. (NASDAQ:GRFS) closed at $10.70 USD , losing $-0.04 (-0.37%) from the previous close of $10.74 . The stock is currently within 5% of its 52-week high $6.19 and $11.14. With a market capitalization of about 9.05 billion Grifols, S.A. is classified as a mega-cap and shows market-like volatility (beta ~0.97). Average daily volume over the past year has been around 985.14 thousand shares, volume is running light vs its 52-week average. Headquartered in Barcelona, None, Grifols, S.A. operates in the Healthcare sector and the Drug Manufacturers - General industry. Led by CEO Jose Ignacio Abia Buenache, the company employs approximately 23,833 people and listed since June 02, 2011. Grifols, S.A.

Technical Performance

GRFS has shown solid momentum, gaining 0.85% over the past week and 36.64% over the past quarter, though year-to-date performance is down 48.96%. Short-term trend indicators are bearishly aligned (SMA20 3.2%, SMA50 11.9%, SMA200 31.28%) The stock’s 14-day RSI is 67.19 (firm momentum), while the ATR of 0.31 points to moderate-to-higher daily volatility. The stock remains hovering near 52-week lows, trading 1107.43% below its high and over 389.55% above its low. Average 10-day trading volume of 1.41 million shares is slightly above the 3-month average of 989.16 thousand , indicating heightened recent market interest.

Frequently Asked Questions

What is the current Grifols, S.A. (GRFS) stock price?

Grifols, S.A. (NASDAQ: GRFS) stock price is $10.70 in the last trading session. During the trading session, GRFS stock reached the peak price of $10.77 while $10.65 was the lowest point it dropped to. The percentage change in GRFS stock occurred in the recent session was -0.37% while the dollar amount for the price change in GRFS stock was -$0.04.

GRFS's industry and sector of operation?

The NASDAQ listed GRFS is part of Drug Manufacturers - General industry that operates in the broader Healthcare sector. Grifols, S.A. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of GRFS?

No Data

How GRFS did perform over past 52-week?

GRFS's closing price is 73.51% higher than its 52-week low of $6.19 where as its distance from 52-week high of $11.14 is -3.59%.

How many employees does GRFS have?

Number of GRFS employees currently stands at 23,833.

Link for GRFS official website?

Official Website of GRFS is: https://www.grifols.com

How do I contact GRFS?

GRFS could be contacted at phone 349 357 10221 and can also be accessed through its website. GRFS operates from Avinguda de la Generalitat, 152, Barcelona, 08174, Spain.

How many shares of GRFS are traded daily?

GRFS stock volume for the day was 373.51K shares. The average number of GRFS shares traded daily for last 3 months was 985.15K.

What is the market cap of GRFS currently?

The market value of GRFS currently stands at $9.05B with its latest stock price at $10.70 and 845.97M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	23833
Beta	1
Sales or Revenue	$6.59B
5Y Sales Change%	0.481%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Drug Manufacturers - General